PUBLISHED ON: November 26, 2015 | Duration: 15 min, 21 sec
Daljeet Kohli, head of research at IndiaNivesh Securities, told NDTV that Dr Reddy's shares were over-owned by the market which led to selloff in the stock. The recent correction in the stock has already factored in the worst-case scenario on account of US FDA warning.
